A meaningful US access gap persists for off-patent biologics lacking viable biosimilar programs, especially mid-tier products ...

While FDA’s draft guidance may alleviate some of the pressures when biosimilar developers, there are still other significant ...

End-to-end digital twins for continuous automated manufacturing could slash production costs compared to batch manufacturing.

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its wholly-owned subsidiary, T-mab, has successfully passed the on-site GMP ...

Cancer therapeutics and orphan drugs are no longer niche areas. Specialty drugs are now a significant portion of the ...

The Sam Chun Dang Pharm incident, where the stock price plummeted by half after briefly reaching the top market ...

With this transaction, Biogen now owns exclusive worldwide development and commercialization rights to felzartamab, consolidating global rights ...

The Downstream Processing Market is entering a high-stakes expansion phase driven by surging biopharmaceutical production, ...

From April 15th to 19th, 2026, Emdoor Digital made a remarkable appearance at this year's Canton Fair, showcasing a revolutionary product lineup that spans high-performance AI laptops, eye-care e-ink ...